Category: Hematology & Oncology
Global Hematology & Oncology
-
2024 Global Hematology and Flow Cytometry Markets: Supplier Shares by Country, Instrumentation Review and Strategic Profiles of Leading Competitors
... of leading hematology and flow cytometry analyzers. Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. Read More
-
2024 Global Hematology and Flow Cytometry Markets: Supplier Shares and Sales Forecasts by Country, Strategic Profiles of Leading Competitors
... testing facilities, as well as test volume, reagent and instrument sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological ... Read More
-
Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024–2029
... staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040, ... Read More
-
Ovarian Cancer Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global ovarian cancer market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global ovarian ... Read More
-
Global Oncology Molecular Diagnostics Market 2024-2028
... oncology molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029
... Forecast to 2029 The global hematology analyzers and reagents market is projected to reach USD 8.8 billion by 2029 from USD 6.6 billion in 2024, growing at a CAGR of 6.1% during the forecast period. ... Read More
-
2024 Global Immunodiagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers
... of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future trends in the U.S., Europe and Asia; provides ... Read More
-
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition
... now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed ... Read More
-
Multi Cancer Early Detection Global Market Report 2024
... Inostics GmbH; Exact Sciences Corporation; Natera Inc; Guardant Health Multi Cancer Early Detection Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Molecular Diagnostics Market Size, Share & Trends by Product & Services (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH, INAAT), Application (Infectious (Hepatitis, HIV, HAI, TB, HPV), Oncology) - Global Forecast to 2029
... Global Forecast to 2029 The molecular diagnostics market is valued at an estimated USD 17.3 billion in 2024 and is projected to reach USD 32.7 billion by 2029 at a CAGR of 13.5% during the ... Read More
-
Esoteric Testing Market by Test Type (Endocrinology, Infectious Disease, Oncology, Neurology, Toxicology, and Others), Technology (Flow Cytometry, Chemiluminescence Immunoassay, Mass Spectrometry, Radio Immunoassay, and Others), Regional Outlook - Global Forecast up to 2030
... the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's ... Read More
-
Global Cancer Diagnostics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Femtech Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Plasma Fractionation Market Research Report Data by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030
... Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030 In 2023, the ... Read More
-
Blood Gas and Electrolyte Analyzers
... is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Combined Analyzers, one of the segments analyzed in the report, is expected to record a 7.0% ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... is expected to reach US$23.8 Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2023-2030. Detection & EnrichmentTechnology, one of the segments analyzed in the report, is expected to record a ... Read More
-
Hematology Instruments and Reagents
... reach US$11.1 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach ... Read More
-
Tissue Diagnostics
... at a CAGR of 6.5% over the analysis period 2023-2030. Tissue Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$8.4 Billion by the end ... Read More
-
Lung Cancer Diagnostics
... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.3 Billion by ... Read More
-
Global Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Regional Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Regional Forecasts 2022-2032 Global Esoteric Testing Market is valued approximately USD 22.06 billion in 2023 and is anticipated to grow ... Read More
-
Clinical Immunoanalyzer Market By Type (ELISA, CLIA, RIA, Others) , By Application (Clinical Chemistry, Endocrinology, Oncology, Infectious Disease Diagnostics, Cardiology, Others) By End user (Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Analysis and Industry Forecast, 2024-2033 The clinical immunoanalyzer market was valued at $4.7 billion in 2023, and is projected to reach $8.0 billion by 2033, growing at a CAGR of 5.5% from 2024 to 2033. ... Read More
-
In Vitro Diagnostic (IVD) Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others), By Use (Clinical Use, Research Use, Others), By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others), By Region and Competition, 2019-2029F
... By Use (Clinical Use, Research Use, Others), By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others), By Region and Competition, 2019-2029F Global In Vitro Diagnostic (IVD) Reagents Market was valued at ... Read More
-
2024 Global: Kidney Cancer Diagnostics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Hematology Oncology Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Colorectal Cancer Screening Tests Market 2024
... can save lives and reduce the burden of this disease on individuals and healthcare systems. Regular screening, tailored to individual risk factors, is a key component of effective colorectal cancer prevention and early detection strategies. ... Read More
Research Assistance
